HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

11.620

-0.920-7.34%

Volume:1.61M

Turnover:19.66M

Market Cap:3.28B

PE:-8.97

High:12.870

Open:12.800

Low:11.610

Close:12.540

52wk High:47.980

52wk Low:10.310

Shares:282.46M

HK Float Shares:282.46M

Volume Ratio:1.25

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.295

ROE:--

ROA:-40.35%

PB:3.62

PE(LYR):-8.97

PS:23.75

Loading ...

Overview Company News Filings

IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs

IMPACT Therapeutics Added to Both Shanghai- and Shenzhen-Hong Kong Stock Connect Lists

Bulletin Express

Impact Therapeutics Added to Shanghai, Shenzhen Stock Connect Eligible List from Sept. 7, 2026

IMPACT THERAP-B Joins Stock Connect, Opening Doors for Mainland Investors

Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal

IMPACT THERAP-B: Sui Xiong Cai Acquires Shares, Long Position Rises to 6.56%

Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%

MT Newswires Live

Hong Kong Stock Market Update: IMPACT THERAP-B (07630) Surges Nearly 13% on Core Drug Growth and Index Inclusion Prospects

Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each

IMPACT Therapeutics CEO Increases Personal Stake to 6.56% via HK$1.46 Million On-Market Purchase

Bulletin Express

Impact Therapeutics - CEO Purchases 100,000 Ordinary Shares at Hk$14.6105 Per Share

THOMSON REUTERS

Impact Therapeutics Says Senaparib EU Marketing Application Under EMA Review, Approval Eyed in 2H 2026

Impact Therapeutics FY26 H1 Net Loss Narrows 29.5% to RMB 90.81 Million; Revenue Rises to RMB 105.19 Million

IMPACT Therapeutics to Join Hang Seng Composite Index

MT Newswires Live

IMPACT Therapeutics to Enter Hang Seng Composite Index, Unlocks Stock Connect Access from 7 September 2026

Bulletin Express

IMPACT THERAP-B (07630) Set to Join Hang Seng Composite Index, Paving Way for Stock Connect Inclusion

IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results

Bulletin Express

Impact Therapeutics Schedules Board Meeting to Review Interim Results

Hong Kong Stock Market Moves: IMPACT THERAP-B Rises Over 3% on Expected Interim Loss Reduction and IMP2794 PCC Nomination

IMPACT THERAP-B Designates IMP2794 as Preclinical Candidate, a Highly Selective KAT6A PROTAC from Its Proprietary Platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrburst.com/stock/07630/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":11.62,"timestamp":1789027722313,"preClose":12.54,"halted":0,"volume":1612000,"delay":0,"changeRate":-0.0733652312599681,"floatShares":282461530,"shares":282461530,"eps":-1.294715,"marketStatus":"Closed","change":-0.92,"latestTime":"09-10 16:08:42","open":12.8,"high":12.87,"low":11.61,"amount":19662852,"amplitude":0.100478,"askPrice":11.85,"askSize":1000,"bidPrice":11.62,"bidSize":15600,"shortable":0,"etf":0,"ttmEps":-1.052,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":12.54,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.246229,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.294715,"volumeRatio":1.246229,"shares":282461530,"dividePrice":0,"high":12.87,"amplitude":0.100478,"preClose":12.54,"low":11.61,"week52Low":10.31,"pbRate":"3.62","psRate":"23.75","week52High":47.98,"institutionHeld":0,"latestPrice":11.62,"committee":0.879518,"eps":-1.294715,"divideRate":0,"volume":1612000,"delay":0,"ttmEps":-1.052,"open":12.8,"prevYearClose":20.1,"prevWeekClose":15.59,"prevMonthClose":14.46,"prevQuarterClose":36.08,"fiveDayClose":14.98,"twentyDayClose":12.11,"sixtyDayClose":37.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"07630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1782230400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-09-09","current":-11.045627,"percent":0.621951,"low":-34.323153,"twenty":-30.033586,"median":-14.62831,"eighty":-10.428386,"high":-8.821219,"avg":-19.298357,"sd":9.364718,"marketCap":3542067586},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-18","current":-29.78235,"twenty":-32.303072,"median":-30.338658,"eighty":-29.742668,"marketCap":10218109810},{"date":"2026-06-26","current":-29.297581,"twenty":-32.241427,"median":-30.11999,"eighty":-29.607619,"marketCap":10002701008},{"date":"2026-07-03","current":-16.26247,"twenty":-32.218614,"median":-29.994357,"eighty":-29.297581,"marketCap":5556442415},{"date":"2026-07-10","current":-15.780707,"twenty":-31.493905,"median":-29.916258,"eighty":-25.475578,"marketCap":5385220035},{"date":"2026-07-17","current":-11.297625,"twenty":-31.022068,"median":-29.816044,"eighty":-15.922995,"marketCap":3869073471},{"date":"2026-07-24","current":-9.271485,"twenty":-30.958502,"median":-29.609087,"eighty":-15.602668,"marketCap":3175898995},{"date":"2026-07-31","current":-10.646015,"twenty":-30.630104,"median":-29.369689,"eighty":-13.307417,"marketCap":3653664669},{"date":"2026-08-07","current":-10.047131,"twenty":-30.493855,"median":-29.24895,"eighty":-10.58915,"marketCap":3454825776},{"date":"2026-08-14","current":-10.299125,"twenty":-30.36699,"median":-25.475578,"eighty":-10.316459,"marketCap":3545960269},{"date":"2026-08-21","current":-10.772628,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"marketCap":3717182649},{"date":"2026-08-28","current":-12.490535,"twenty":-30.224959,"median":-15.896725,"eighty":-10.316459,"marketCap":4310937679},{"date":"2026-09-04","current":-14.62831,"twenty":-30.072679,"median":-15.691688,"eighty":-10.353511,"marketCap":4403575252},{"date":"2026-09-09","current":-11.747651,"twenty":-30.033586,"median":-14.62831,"eighty":-10.428386,"marketCap":3542067586}],"updateTime":1789039566738},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197643588","title":"IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=1197643588","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197643588?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:30","pubTimestamp":1788755416,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) has officially announced its inclusion in the eligible securities lists for both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.According...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126511990","title":"IMPACT Therapeutics Added to Both Shanghai- and Shenzhen-Hong Kong Stock Connect Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=1126511990","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126511990?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:20","pubTimestamp":1788754853,"startTime":"0","endTime":"0","summary":"On 7 September 2026, IMPACT Therapeutics, Inc. (IMPACT Therapeutics) announced that its H shares have been admitted to the list of eligible securities under the Shanghai-Hong Kong Stock Connect and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396024","title":"Impact Therapeutics Added to Shanghai, Shenzhen Stock Connect Eligible List from Sept. 7, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396024","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396024?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:08","pubTimestamp":1788754103,"startTime":"0","endTime":"0","summary":"Impact Therapeutics added to Shanghai, Shenzhen Stock Connect eligible list from Sept. 7, 2026Impact Therapeutics’ H shares will be added to the eligible stock lists for Shanghai-Hong Kong Stock Conne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL5FXGKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193162585","title":"IMPACT THERAP-B Joins Stock Connect, Opening Doors for Mainland Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1193162585","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193162585?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:10","pubTimestamp":1788523816,"startTime":"0","endTime":"0","summary":"The Shanghai Stock Exchange announced after market close on September 4th that, in accordance with the relevant provisions of the \"Shanghai-Hong Kong Stock Connect Implementation Measures,\" IMPACT...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171709484","title":"Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1171709484","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171709484?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435272,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange reveals that on September 1, Cai Suixiong increased his holding in IMPACT THERAP-B (07630) by 100,000 shares at a price of HK$14.6105 per share, totaling...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121401584","title":"IMPACT THERAP-B: Sui Xiong Cai Acquires Shares, Long Position Rises to 6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121401584","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121401584?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:50","pubTimestamp":1788429051,"startTime":"0","endTime":"0","summary":"On September 1, 2026, Sui Xiong Cai bought 100,000 shares of IMPACT THERAP-B (07630) at an average of HKD 14.6105 per share, involving about HKD 1.46 million.Prior to the acquisition, Sui Xiong Cai's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820481","title":"Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820481?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:53","pubTimestamp":1788425601,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed lower on Thursday as rising bond yields and oil prices increased concerns over U.S. interest rates and monetary policy.The Hang Seng Index fell 97.90 points, or 0.4%, to close at 25,213.31, while the Hang Seng China Enterprises Index dropped 64.86 points, or 0.8%, to 8,385.24.Global bond prices fell, with U.S. Treasury yields reaching their highest levels since 2023, while higher oil prices added to inflation concerns.Investors also remained cautious amid renewed U.S.-Iran attacks and awaited Friday's U.S. payrolls report for clues on the Federal Reserve's next move. Markets have raised the odds of a 25-basis-point rate hike this month to about 62% from 37% a week ago, according to a Reuters report.In corporate developments, HUTCHMED   jumped more than 14% after agreeing to grant a GSK subsidiary worldwide rights, excluding Mainland China, Hong Kong, Macau and Taiwan, to develop and commercialize its experimental cancer drug HMPL-A830 for up to $1.30 billion.Sep","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MHImain","BK1161","03419","02833","513600","07500","BK1587","HSTECH","07630","03037","MCHmain","02800","BK1588","03115","HHImain","82800","HCM","07300","09115","83115","00013","BK1191","07200","HSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102771982","title":"Hong Kong Stock Market Update: IMPACT THERAP-B (07630) Surges Nearly 13% on Core Drug Growth and Index Inclusion Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1102771982","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102771982?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:18","pubTimestamp":1788419895,"startTime":"0","endTime":"0","summary":"Shares of IMPACT THERAP-B (07630) jumped nearly 13% in Hong Kong trading, last up 11.14% at HK$14.87 with turnover reaching HK$5.15 million.In a morning announcement, the company disclosed that its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK1161","VXUS","KCAI","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664131847","title":"Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664131847","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664131847?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:33","pubTimestamp":1788395580,"startTime":"0","endTime":"0","summary":"Impact Therapeutics CEO Cai lifts stake to 6.56% after buying 100,000 shares at HK$14.61 eachCEO Sui Xiong Cai bought 100,000 ordinary shares in the open market, lifting his stake to 6.56%.Purchase pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1nSkS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120376512","title":"IMPACT Therapeutics CEO Increases Personal Stake to 6.56% via HK$1.46 Million On-Market Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1120376512","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120376512?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:23","pubTimestamp":1788394986,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. (IMPACT THERAP-B) disclosed that Executive Director and Chief Executive Officer Dr. Sui Xiong Cai acquired 100,000 ordinary shares in the open market at an average price of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842249","title":"Impact Therapeutics - CEO Purchases 100,000 Ordinary Shares at Hk$14.6105 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842249","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842249?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:02","pubTimestamp":1788393730,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U19D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663730330","title":"Impact Therapeutics Says Senaparib EU Marketing Application Under EMA Review, Approval Eyed in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663730330","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663730330?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165237,"startTime":"0","endTime":"0","summary":"Impact Therapeutics says senaparib EU marketing application under EMA review, approval eyed in 2H 2026Impact Therapeutics’ senaparib ovarian-cancer maintenance filing with the EMA was accepted in Augu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL4HjK0z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073702","title":"Impact Therapeutics FY26 H1 Net Loss Narrows 29.5% to RMB 90.81 Million; Revenue Rises to RMB 105.19 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073702","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073702?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165221,"startTime":"0","endTime":"0","summary":"Impact Therapeutics FY26 H1 net loss narrows 29.5% to RMB 90.81 million; revenue rises to RMB 105.19 millionImpact Therapeutics reported revenue of RMB 105.19 million, up more than quadrupled from a y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL7fVJfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661268247","title":"IMPACT Therapeutics to Join Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2661268247","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661268247?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:19","pubTimestamp":1787541578,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics (HKG:7630) will be added to the Hang Seng Composite Index from Sept. 7, according to a Monday Hong Kong bourse filing.Its shares are also expected to meet the criteria to be traded through the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","KWEB","07630","82822","02822","02843","ASHS","XPP","BK4139","FLCH","KCAI","YXI","BK1161","LENZ","CHAU","HSCI","CWEB","YINN","KBA","BK4539","YANG","FXP","BK4007","82823","ASHR","82843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143127061","title":"IMPACT Therapeutics to Enter Hang Seng Composite Index, Unlocks Stock Connect Access from 7 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1143127061","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143127061?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:50","pubTimestamp":1787529011,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. announced that Hang Seng Indexes Company Limited has selected the group as a constituent of the Hang Seng Composite Index (HSCI), effective 7 September 2026. The inclusion...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165050593","title":"IMPACT THERAP-B (07630) Set to Join Hang Seng Composite Index, Paving Way for Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1165050593","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165050593?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:02","pubTimestamp":1787313754,"startTime":"0","endTime":"0","summary":"On August 21, 2026, Hang Seng Indexes Company unveiled the results of its quarterly index review as of June 30, 2026, with IMPACT THERAP-B (07630) being added to the Hang Seng Composite Index. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCI","BK1161","FLHK","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122709213","title":"IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1122709213","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122709213?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:47","pubTimestamp":1787129230,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456604","title":"Impact Therapeutics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456604?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:38","pubTimestamp":1787128710,"startTime":"0","endTime":"0","summary":"Impact Therapeutics schedules board meeting to review interim resultsImpact Therapeutics scheduled a board meeting for Aug. 31, 2026 to review unaudited interim results for the six months ended June 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL59SYZv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162268658","title":"Hong Kong Stock Market Moves: IMPACT THERAP-B Rises Over 3% on Expected Interim Loss Reduction and IMP2794 PCC Nomination","url":"https://stock-news.laohu8.com/highlight/detail?id=1162268658","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162268658?lang=en_us&edition=fundamental","pubTime":"2026-08-14 13:52","pubTimestamp":1786686736,"startTime":"0","endTime":"0","summary":"Shares of IMPACT THERAP-B (07630) climbed more than 3% in early trading, last up 2.64% at HKD 12.43, with a turnover of approximately HKD 3.06 million.On the news front, IMPACT THERAP-B recently...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","KCAI","VXUS","PPC","07630","BK1161","BK4212","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133174395","title":"IMPACT THERAP-B Designates IMP2794 as Preclinical Candidate, a Highly Selective KAT6A PROTAC from Its Proprietary Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1133174395","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133174395?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:20","pubTimestamp":1786526417,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) announced that it has designated IMP2794 as a preclinical candidate compound (PCC), a KAT6A-specific degrader PROTAC discovered through its proprietary targeted protein...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":85,"code":"91000000","status":"200"}]}}